Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
14 Feb 24 | ONCT Oncternal Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 9.18 | 14,200 | 130.36 k | 14,200 |
3 Jan 24 | ONCT Oncternal Therapeutics | Common Stock | Payment of exercise | Dispose F | No | No | 0.4961 | 19,742 | 9.79 k | 128,635 |
2 Oct 23 | ONCT Oncternal Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.31 | 70,600 | 21.89 k | 70,600 |
2 Oct 23 | ONCT Oncternal Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.31 | 210,000 | 65.10 k | 210,000 |
2 Oct 23 | ONCT Oncternal Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.31 | 55,000 | 17.05 k | 55,000 |
2 Oct 23 | ONCT Oncternal Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.31 | 92,075 | 28.54 k | 92,075 |
2 Oct 23 | ONCT Oncternal Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.31 | 354,400 | 109.86 k | 354,400 |
2 Oct 23 | ONCT Oncternal Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 0.96 | 210,000 | 201.60 k | 0 |
2 Oct 23 | ONCT Oncternal Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 1.04 | 55,000 | 57.20 k | 0 |
2 Oct 23 | ONCT Oncternal Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 1.94 | 92,075 | 178.63 k | 0 |